Case series: use of ziprasidone for maladaptive symptoms in youths with autism.


OBJECTIVE To conduct a preliminary evaluation of the safety and effectiveness of ziprasidone in children, adolescents, and young adults with autism. METHOD Twelve patients (mean age +/- SD, 11.62 +/- 4.38 years; range, 8-20 years) with DSM-IV-defined autism (n = 9) or pervasive developmental disorder not otherwise specified (n = 3) received open-label… (More)


  • Presentations referencing similar topics